Review



human her2 positive bc cell lines bt474  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC human her2 positive bc cell lines bt474
    Human Her2 Positive Bc Cell Lines Bt474, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4002 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bt474+cells/BT-474/pm42214708-57-7-24
    Average 99 stars, based on 4002 article reviews
    human her2 positive bc cell lines bt474 - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    other:

    Article Title: Antibody-immune agonist conjugate and applications thereof
    Article Snippet: MS: Thermo Fisher Q Exactive Plus, Water2795-Quattro micro triple quadrupole mass spectrometer HPLC: Waters 2695, Agilent 1100, Agilent 1200 Semi-preparative HPLC: Lisure HP plus 50D Flow Cytometry: CytoFLEX S HIC-HPLC: Butyl-HIC; mobile phase A: 25 mM PB, 2M (NH4)2SO4, pH 7.0; mobile phase B: 25 mM PB, pH 7.0; flow rate: 0.8 ml/min; acquisition time: 25 min; injection amount: 20 μg; column temperature: 25° C.; detection wavelength: 280 nm; sample chamber temperature: 8° C. SEC-HPLC: column: TSK-gel G3000 SWXL, TOSOH 7.8 mm ID×300 mm, 5 μm; mobile phase: 0.2 M KH2PO4, 0.25 M KCl, pH 6.2; flow rate: 0.5 ml/min; acquisition time: 30 min; injection volume: 50 μl; column temperature: 25° C.; detection wavelength; 280 nm; sample tray temperature: 8° C. CHO was obtained from Thermo Fisher Scientific; pcDNA 3.3 was obtained from Life Technology; HEK293F was obtained from Prejin; PEIMAX transfection reagent was obtained from Polyscience; MabSelect Sure ProA was obtained from GE; Capto S ImpAct was obtained from GE; Rink-amide-MBNA-resin and dichloro resin were obtained from Nankai synthesis; HCC1954 was obtained from ATCC CAT #CRL-2338; SK-BR-3 was obtained from ATCC CAT #HTB-30; BT474 cells was obtained from ATCC CAT #HTB-20; JIMT1 cells was obtained from DSMZ CAT #ACC589; Colo205 cells was obtained from ATCC CAT #CRL-222; NCI-N87—Claudin 18.2 human gastric cancer cells was obtained from KYinno Biotechnology Co., Ltd; Claudin 18.2-negative NCI-N87 parental cells was obtained from ATCC CAT #CRL-5822; MC38hHER2 murine colorectal cancer cells was obtained from Biocytogen; NUGC4 human gastric cancer cells was obtained from JCRB CAT #JCRB0834; NCI-N87 cells (ATCC CAT #CRL-5822); MDA-MB-468 was obtained from ATCC CAT #HTB-132.

    Cell Culture:

    Article Title: Evaluating the Translation Value of Two In Vivo Models for Breast Cancer Brain Metastases
    Article Snippet: .. BT474 cells (ATCC, #HTB-20, Manassas, VA, USA) were cultured in DMEM: RPMI 1640 (1:1) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin (P/S). .. MDA-MB-231.Luc2 (Caliper Life Science, Hopkinton, MA, USA) were cultured in Leibovitz’s L-15 medium supplemented with 15% FBS, 1% P/S and 2 mM glutamine.

    Article Title: Evaluating the Translation Value of Two In Vivo Models for Breast Cancer Brain Metastases.
    Article Snippet: .. BT474 cells (ATCC, #HTB-20, Manassas, VA, USA) were cultured in DMEM: RPMI 1640 (1:1) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin (P/S). .. MDA-MB-231.Luc2 (Caliper Life Science, Hopkinton, MA, USA) were cultured in Leibovitz’s L-15 medium supplemented with 15% FBS, 1% P/S and 2 mM glutamine.



    Similar Products

    human her2 positive bc cell lines bt474  (ATCC)
    99
    ATCC human her2 positive bc cell lines bt474
    Human Her2 Positive Bc Cell Lines Bt474, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bt474+cells/BT-474/pm42214708-57-7-24
    Average 99 stars, based on 1 article reviews
    human her2 positive bc cell lines bt474 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    human her2 female breast cancer cell lines bt474 ts  (ATCC)
    99
    ATCC human her2 female breast cancer cell lines bt474 ts
    Human Her2 Female Breast Cancer Cell Lines Bt474 Ts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bt474+cells/BT-474/pm42115409-59-0-19
    Average 99 stars, based on 1 article reviews
    human her2 female breast cancer cell lines bt474 ts - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    bt474 cells  (ATCC)
    99
    ATCC bt474 cells
    Bt474 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bt474+cells/BT-474/pm41976318-58-0-2
    Average 99 stars, based on 1 article reviews
    bt474 cells - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    cell culture bt474  (ATCC)
    99
    ATCC cell culture bt474
    Cell Culture Bt474, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bt474+cells/BT-474/pm41957225-55-0-19
    Average 99 stars, based on 1 article reviews
    cell culture bt474 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    blasticidin s bt474 cells  (Korean Cell Line Bank)
    86
    Korean Cell Line Bank blasticidin s bt474 cells
    Blasticidin S Bt474 Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bt474+cells/474+bt/10__1002_slash_admt__202502210-197-23-29
    Average 86 stars, based on 1 article reviews
    blasticidin s bt474 cells - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    brca cell lines bt474  (DSMZ)
    95
    DSMZ brca cell lines bt474
    SH3-domain containing GRB2-like 1 ( SH3GL1 ) is generally highly expressed in breast cancer (BRCA) and is closely related to a variety of immune cells. (A) Hematoxylin and eosin (H&E) staining diagram of BRCA and immunohistochemistry (IHC) staining diagram of breast markers, including pan-cytokeratin, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2). (B) Western blot analysis of the protein expression levels of SH3GL1 in tissues of BRCA and adjacent normal tissue (Adj). ∗∗∗ P < 0.001, in comparison with Adj. (C) Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to detect the mRNA expression level of SH3GL1 in BRCA and Adj in clinical samples, ∗∗∗ P < 0.001, in comparison with Adj. (D) Flow cytometry for the proportion of natural killer (NK) cells, T cells, B cells, regulatory T cells (Treg), M0, M1, dendritic cell (DC) and mast cell in the tissues of BRCA and Adj, ∗∗∗ P < 0.001, in comparison with Adj. (E) RT-qPCR to detect the expression level of SH3GL1 in commonly used BRCA cell lines. Among them, MCF-10A was normal breast epithelial cell, <t>BT474:</t> three Yang; SKBR3: HER2 high expression; MCF-7: ER + ; MDA-MB-453: ER-HER2 + ; MDA-MB-231: Three Yin. ∗ indicates comparison with MCF-10A. ∗∗ P < 0.01, ∗∗∗ P < 0.001. (F, G) Western blot analysis of the protein expression level of SH3GL1 in commonly used BRCA cell lines. In comparison with MCF-10A, ∗ P < 0.01, ∗∗ P < 0.01, ∗∗∗ P < 0.001. The expression values for different cell types were not ordered according to any specific rank. M0/M1: macrophage subtypes. TNBC: triple-negative breast cancer; GAPDH: glyceraldehyde-3-phosphate dehydrogenase. BCRA-1 and BCRA-2 represent breast cancer samples obtained from two independent patients.
    Brca Cell Lines Bt474, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bt474+cells/BT-474/pmc12861226-176-4-67
    Average 95 stars, based on 1 article reviews
    brca cell lines bt474 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    SH3-domain containing GRB2-like 1 ( SH3GL1 ) is generally highly expressed in breast cancer (BRCA) and is closely related to a variety of immune cells. (A) Hematoxylin and eosin (H&E) staining diagram of BRCA and immunohistochemistry (IHC) staining diagram of breast markers, including pan-cytokeratin, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2). (B) Western blot analysis of the protein expression levels of SH3GL1 in tissues of BRCA and adjacent normal tissue (Adj). ∗∗∗ P < 0.001, in comparison with Adj. (C) Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to detect the mRNA expression level of SH3GL1 in BRCA and Adj in clinical samples, ∗∗∗ P < 0.001, in comparison with Adj. (D) Flow cytometry for the proportion of natural killer (NK) cells, T cells, B cells, regulatory T cells (Treg), M0, M1, dendritic cell (DC) and mast cell in the tissues of BRCA and Adj, ∗∗∗ P < 0.001, in comparison with Adj. (E) RT-qPCR to detect the expression level of SH3GL1 in commonly used BRCA cell lines. Among them, MCF-10A was normal breast epithelial cell, BT474: three Yang; SKBR3: HER2 high expression; MCF-7: ER + ; MDA-MB-453: ER-HER2 + ; MDA-MB-231: Three Yin. ∗ indicates comparison with MCF-10A. ∗∗ P < 0.01, ∗∗∗ P < 0.001. (F, G) Western blot analysis of the protein expression level of SH3GL1 in commonly used BRCA cell lines. In comparison with MCF-10A, ∗ P < 0.01, ∗∗ P < 0.01, ∗∗∗ P < 0.001. The expression values for different cell types were not ordered according to any specific rank. M0/M1: macrophage subtypes. TNBC: triple-negative breast cancer; GAPDH: glyceraldehyde-3-phosphate dehydrogenase. BCRA-1 and BCRA-2 represent breast cancer samples obtained from two independent patients.

    Journal: Journal of Pharmaceutical Analysis

    Article Title: Targeting SH3GL1 for prognosis and immune response in breast cancer

    doi: 10.1016/j.jpha.2025.101377

    Figure Lengend Snippet: SH3-domain containing GRB2-like 1 ( SH3GL1 ) is generally highly expressed in breast cancer (BRCA) and is closely related to a variety of immune cells. (A) Hematoxylin and eosin (H&E) staining diagram of BRCA and immunohistochemistry (IHC) staining diagram of breast markers, including pan-cytokeratin, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2). (B) Western blot analysis of the protein expression levels of SH3GL1 in tissues of BRCA and adjacent normal tissue (Adj). ∗∗∗ P < 0.001, in comparison with Adj. (C) Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to detect the mRNA expression level of SH3GL1 in BRCA and Adj in clinical samples, ∗∗∗ P < 0.001, in comparison with Adj. (D) Flow cytometry for the proportion of natural killer (NK) cells, T cells, B cells, regulatory T cells (Treg), M0, M1, dendritic cell (DC) and mast cell in the tissues of BRCA and Adj, ∗∗∗ P < 0.001, in comparison with Adj. (E) RT-qPCR to detect the expression level of SH3GL1 in commonly used BRCA cell lines. Among them, MCF-10A was normal breast epithelial cell, BT474: three Yang; SKBR3: HER2 high expression; MCF-7: ER + ; MDA-MB-453: ER-HER2 + ; MDA-MB-231: Three Yin. ∗ indicates comparison with MCF-10A. ∗∗ P < 0.01, ∗∗∗ P < 0.001. (F, G) Western blot analysis of the protein expression level of SH3GL1 in commonly used BRCA cell lines. In comparison with MCF-10A, ∗ P < 0.01, ∗∗ P < 0.01, ∗∗∗ P < 0.001. The expression values for different cell types were not ordered according to any specific rank. M0/M1: macrophage subtypes. TNBC: triple-negative breast cancer; GAPDH: glyceraldehyde-3-phosphate dehydrogenase. BCRA-1 and BCRA-2 represent breast cancer samples obtained from two independent patients.

    Article Snippet: In this study, the BRCA cell lines BT474 (human breast ductal carcinoma cell line, BFN60700229), SKBR3 (human BRCA cell line, BFN60700185), MCF-7 (human BRCA cell line, BFN607200603), MDA-MB-231 (human BRCA cell line, BFN608008564), and MDA-MB-453 (human BRCA cell line, BFN60700116), as well as the normal breast cell line MCF-10A (human breast epithelial cells, BFN60805246) were all purchased from BLUEFBIO (Shenzhen, Guangdong, China) and authenticated by the German DSMZ Leibniz Research Institute in November 2017 and June 2018 using a nano-composite PCR-based (short tandem repeat) STR profile.

    Techniques: Staining, Immunohistochemistry, Western Blot, Expressing, Comparison, Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Flow Cytometry

    SH3-domain containing GRB2-like 1 ( SH3GL1 ) in breast cancer (BRCA) epithelial cells promotes their interaction with immune cells. (A) The mRNA expression level of SH3GL1 in normal organoids (Normal-Orgs) and BRCA organoids (BRCA-Orgs) was detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR). ∗∗ P < 0.01, in comparison with Normal-Orgs. (B) Western blot analysis of SH3GL1 protein expression in Normal-Orgs and BRCA-Orgs. ∗∗ P < 0.01, in comparison with Normal-Orgs. (C) RT-qPCR to detect the mRNA expression level of SH3GL1 in BRCA-Orgs and BT474 before and after co-culture. (D) Western blot analysis of SH3GL1 protein levels in BRCA-Orgs and BT474 before and after co-culture. (E) RT-qPCR to detect mRNA expression of tumor susceptibility marker CD44 in BRCA-Orgs and BT474 before and after co-culture. (F) Representative pictures of proliferating marker Ki67 in BRCA-Orgs before and after co-culture detected by IHC. (G) Statistics of the maximum passage times of BRCA-Orgs before and after co-culture. (H) Statistics on the number of BRCA-Orgs formed from single cells to organoids before and after co-culture. (I) Representative pictures of 5-ethynyl-2′-deoxyuridine (EdU) staining of BT474 cells before and after co-culture. The right side is the relative statistical map of EdU positive cells. (J) Representative images of scratch migration experiment of BT474 cells before and after co-culture. Statistical map of relative scratch closure area on the right. (K) RT-qPCR to detect the mRNA expression of SH3GL1 before and after co-culture of BRCA-Orgs and MDA-MB-231 after knockdown of SH3GL1 . (L,M) Western blot analysis of SH3GL1 protein expression in BRCA-Orgs and MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown (L), and the statistical chart (M). (N) Representative pictures of proliferation marker Ki67 before and after co-culture detected by IHC after BCRA-Orgs SH3GL1 knockdown, and statistical graph. (O) Representative pictures of EdU staining of MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown (red is EdU positive cells), and the relative statistical map of EdU positive cells. (P) Representative images of scratch migration experiment of MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown, and statistical map of relative scratch closure area. In the D–P plots, ∗∗ P < 0.01, ∗∗∗ P < 0.001. (Q) Representative picture of transwell migration induced PBMC (T cells) to BRCA-Orgs, Where fluorescence represents T cells, and statistical graph on the right. In the Q plot, ∗∗∗ P < 0.001, in comparison with Normal-Orgs or shNC. IHC: immunohistochemistry; CD44: tumor susceptibility marker; transwell: migration assay system; PBMC: peripheral blood mononuclear cells.

    Journal: Journal of Pharmaceutical Analysis

    Article Title: Targeting SH3GL1 for prognosis and immune response in breast cancer

    doi: 10.1016/j.jpha.2025.101377

    Figure Lengend Snippet: SH3-domain containing GRB2-like 1 ( SH3GL1 ) in breast cancer (BRCA) epithelial cells promotes their interaction with immune cells. (A) The mRNA expression level of SH3GL1 in normal organoids (Normal-Orgs) and BRCA organoids (BRCA-Orgs) was detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR). ∗∗ P < 0.01, in comparison with Normal-Orgs. (B) Western blot analysis of SH3GL1 protein expression in Normal-Orgs and BRCA-Orgs. ∗∗ P < 0.01, in comparison with Normal-Orgs. (C) RT-qPCR to detect the mRNA expression level of SH3GL1 in BRCA-Orgs and BT474 before and after co-culture. (D) Western blot analysis of SH3GL1 protein levels in BRCA-Orgs and BT474 before and after co-culture. (E) RT-qPCR to detect mRNA expression of tumor susceptibility marker CD44 in BRCA-Orgs and BT474 before and after co-culture. (F) Representative pictures of proliferating marker Ki67 in BRCA-Orgs before and after co-culture detected by IHC. (G) Statistics of the maximum passage times of BRCA-Orgs before and after co-culture. (H) Statistics on the number of BRCA-Orgs formed from single cells to organoids before and after co-culture. (I) Representative pictures of 5-ethynyl-2′-deoxyuridine (EdU) staining of BT474 cells before and after co-culture. The right side is the relative statistical map of EdU positive cells. (J) Representative images of scratch migration experiment of BT474 cells before and after co-culture. Statistical map of relative scratch closure area on the right. (K) RT-qPCR to detect the mRNA expression of SH3GL1 before and after co-culture of BRCA-Orgs and MDA-MB-231 after knockdown of SH3GL1 . (L,M) Western blot analysis of SH3GL1 protein expression in BRCA-Orgs and MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown (L), and the statistical chart (M). (N) Representative pictures of proliferation marker Ki67 before and after co-culture detected by IHC after BCRA-Orgs SH3GL1 knockdown, and statistical graph. (O) Representative pictures of EdU staining of MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown (red is EdU positive cells), and the relative statistical map of EdU positive cells. (P) Representative images of scratch migration experiment of MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown, and statistical map of relative scratch closure area. In the D–P plots, ∗∗ P < 0.01, ∗∗∗ P < 0.001. (Q) Representative picture of transwell migration induced PBMC (T cells) to BRCA-Orgs, Where fluorescence represents T cells, and statistical graph on the right. In the Q plot, ∗∗∗ P < 0.001, in comparison with Normal-Orgs or shNC. IHC: immunohistochemistry; CD44: tumor susceptibility marker; transwell: migration assay system; PBMC: peripheral blood mononuclear cells.

    Article Snippet: In this study, the BRCA cell lines BT474 (human breast ductal carcinoma cell line, BFN60700229), SKBR3 (human BRCA cell line, BFN60700185), MCF-7 (human BRCA cell line, BFN607200603), MDA-MB-231 (human BRCA cell line, BFN608008564), and MDA-MB-453 (human BRCA cell line, BFN60700116), as well as the normal breast cell line MCF-10A (human breast epithelial cells, BFN60805246) were all purchased from BLUEFBIO (Shenzhen, Guangdong, China) and authenticated by the German DSMZ Leibniz Research Institute in November 2017 and June 2018 using a nano-composite PCR-based (short tandem repeat) STR profile.

    Techniques: Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Comparison, Western Blot, Co-Culture Assay, Marker, Staining, Migration, Knockdown, Fluorescence, Immunohistochemistry, Transwell Migration Assay